Juventas Cell Therapy Ltd.
Clinical trials sponsored by Juventas Cell Therapy Ltd., explained in plain language.
-
Can engineered immune cells tame autoimmune anemia?
⭐️ CURE ⭐️ Recruiting nowThis early-stage trial is testing an experimental treatment called HY001N, a type of CAR-T cell therapy, in adults with autoimmune hemolytic anemia (AIHA) who have not improved after three or more standard treatments. The goal is to see if the therapy is safe and tolerable, and w…
Phase: PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: ⭐️ CURE ⭐️
Last updated Aug 07, 2026 00:00 UTC
-
Experimental cell therapy targets Hard-to-Treat nerve diseases
Disease control Recruiting nowThis early-stage study tests a new cell therapy called CNCT19 in 18 adults with relapsed or treatment-resistant autoimmune neurological diseases like neuromyelitis optica. The goal is to see if it is safe and can help control the disease by targeting certain immune cells. Partici…
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC